Correlation Engine 2.0
Clear Search sequence regions


Gemcitabine is a cytotoxic nucleoside analog, which is widely used in the treatment of malignancies. Interindividual differences in gemcitabine pharmacokinetics and pharmacodynamics have been demonstrated. Pharmacogenetic factors may account for a significant proportion of these differences. This review provides an update on the pharmacogenetics of gemcitabine and its influence on gemcitabine efficacy and toxicity.

Citation

Andrea Wong, Ross A Soo, Wei-Peng Yong, Federico Innocenti. Clinical pharmacology and pharmacogenetics of gemcitabine. Drug metabolism reviews. 2009;41(2):77-88

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 19514966

View Full Text